Sunshine Biopharma Inc (SBFM):企業の財務・戦略的SWOT分析

◆英語タイトル:Sunshine Biopharma Inc (SBFM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14768
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥40,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥81,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥122,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acute and chronic indications. It offers drug candidate such as Adva-27a, a small molecule against different types of multidrug resistant cancer cell lines. Sunshine BioPharma also offers difluoro-etoposide, which is a multipurpose anti-tumor compound. The company’s products are used in the treatment of breast cancer, uterine carcinoma, pancreatic cancer and small-cell lung cancer, kidney cancer and squamous-cell carcinomas, among others. Sunshine BioPharma is headquartered in Pointe-Claire, Quebec, Canada.

Sunshine Biopharma Inc Key Recent Developments

Dec 17,2018: Sunshine Biopharma receives Health Canada approval for Essential 9TM, the company’s first over the counter essential micronutrient
Aug 16,2018: Sunshine Biopharma signs a service agreement with utah based Quintessential Biosciences
Jun 18,2018: Sunshine Biopharma Launches Microbiology Testing Service
May 10,2018: Sunshine Biopharma Announces Extension of The Term of Its Brokered Up To $10 Million Private Placement Financing

This comprehensive SWOT profile of Sunshine Biopharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sunshine Biopharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Sunshine Biopharma Inc – Key Information
Sunshine Biopharma Inc – Overview
Sunshine Biopharma Inc – Key Employees
Sunshine Biopharma Inc – Key Employee Biographies
Sunshine Biopharma Inc – Key Operational Heads
Sunshine Biopharma Inc – Major Products and Services
Sunshine Biopharma Inc – History
Sunshine Biopharma Inc – Company Statement
Sunshine Biopharma Inc – Locations And Subsidiaries
Sunshine Biopharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Sunshine Biopharma Inc – Business Description
Sunshine Biopharma Inc – Corporate Strategy
Sunshine Biopharma Inc – SWOT Analysis
SWOT Analysis – Overview
Sunshine Biopharma Inc – Strengths
Sunshine Biopharma Inc – Weaknesses
Sunshine Biopharma Inc – Opportunities
Sunshine Biopharma Inc – Threats
Sunshine Biopharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Sunshine Biopharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Sunshine Biopharma Inc, Key Information
Sunshine Biopharma Inc, Key Ratios
Sunshine Biopharma Inc, Share Data
Sunshine Biopharma Inc, Major Products and Services
Sunshine Biopharma Inc, History
Sunshine Biopharma Inc, Key Employees
Sunshine Biopharma Inc, Key Employee Biographies
Sunshine Biopharma Inc, Key Operational Heads
Sunshine Biopharma Inc, Other Locations
Sunshine Biopharma Inc, Subsidiaries
Sunshine Biopharma Inc, Key Manufacturing facilities
Sunshine Biopharma Inc, Key Competitors
Sunshine Biopharma Inc, SWOT Analysis
Sunshine Biopharma Inc, Ratios based on current share price
Sunshine Biopharma Inc, Annual Ratios
Sunshine Biopharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Sunshine Biopharma Inc, Performance Chart
Sunshine Biopharma Inc, Ratio Charts

★海外企業調査レポート[Sunshine Biopharma Inc (SBFM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tosk Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tosk Inc (Tosk) is a drug developing company that provides development of safety and efficacy conditions of drugs. The company discovers and develops new drugs for cancer and other conditions using non-mammalian animal species as models for human diseases. It provides optimizing marketed dru …
  • AeroParts Manufacturing & Repair, Inc:企業の戦略・SWOT・財務情報
    AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report Summary AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Arcus SA (ARC):企業の財務・戦略的SWOT分析
    Summary Arcus SA (Arcus) is an information technology service provider that offers integrated systems for document management and mass correspondence management. Its product includes tims controlling system, which is used for telematics operation. It provides document management products such as pri …
  • Vstecs Holdings Ltd
    Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Republic Airline, Inc.:企業の戦略・SWOT・財務情報
    Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ChemAxon Kft:医療機器:M&Aディール及び事業提携情報
    Summary ChemAxon Kft (ChemAxon) is a provider of software platforms. The company provides chemistry and biology software solutions and consultancy services that help in optimizing the value of chemistry information in life sciences and research and development. Its product portfolio consists of desk …
  • Eaton Corporation plc:企業の戦略・SWOT・財務情報
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Volga Gas plc (VGAS):企業の財務・戦略的SWOT分析
    Summary Volga Gas Plc (Volga Gas) is an oil and gas company that provides oil and gas exploration and production services. The company acquires, produces and develops oil, natural gas deposit properties, and others. It owns and operates oil and gas producing assets in Karpenskiy licence area, Pre-Ca …
  • Edcon Holdings (Proprietary) Limited:戦略・SWOT・企業財務分析
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Greensmith Energy Management Systems LLC-エネルギー分野:企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Dongkook Pharmaceutical Co Ltd (086450)-製薬・医療分野:企業M&A・提携分析
    Summary Dongkook Pharmaceutical Co Ltd (Dongkook) formerly known as UEC & Co. Ltd, is a pharmaceutical company which develops, manufacture and distributes pharmaceutical products, health care products and medical devices. It offers pharmaceutical products such as antibiotics, anodynes, vitamins, wou …
  • Desjardins Financial Security Life Assurance Company:企業の戦略・SWOT・財務情報
    Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • Central National Gottesman Inc:企業の戦略・SWOT・財務分析
    Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report Summary Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tesla Inc (TSLA):企業の財務・戦略的SWOT分析
    Tesla Inc (TSLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Caspian Energy Inc. (CKZ.H)-石油・ガス分野:企業M&A・提携分析
    Summary Caspian Energy Inc. (Caspian) is an independent upstream oil and gas company that explores for and develops hydrocarbon reserves, and produces oil and gas. Caspian and its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license which entitles it to explore …
  • Achelios Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topof …
  • NW Natural Gas Co:企業の戦略的SWOT分析
    NW Natural Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • B3 S.A.:企業の戦略・SWOT・財務分析
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆